82
Views
18
CrossRef citations to date
0
Altmetric
Review

Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination

, , , &
Pages 2973-2987 | Published online: 21 May 2018

References

  • HanSClinical vaccine developmentClin Exp Vaccine Res20154465325648742
  • SilinDSLyubomskaOVJirathitikalVOral vaccination: where we are?Expert Opin Drug Del20074323340
  • MitragotriSLahannJPhysical approaches to biomaterial designNat Mater20098152319096389
  • ShahPKChyuKYFredriksonGNNilssonJImmunomodulation of atherosclerosis with a vaccineNat Clin Pract Cardiovasc Med2005263964616306920
  • SinghSYangGSchlunsKSAnthonySMSastryKJSublingual vaccination induces mucosal and systemic adaptive immunity for protection against lung tumor challengePLoS One20149e9000124599269
  • HillemanMRVaccines in historic evolution and perspective: a narrative of vaccine discoveriesVaccine2000181436144710618541
  • JosephAItskovitz-CooperNSamiraSA new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in miceVaccine2006243990400616516356
  • ZhuQTaltonJZhangGLarge intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infectionNat Med2012181291129622797811
  • BelyakovIMHelZKelsallBMucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaquesNat Med200171320132611726972
  • RagotCGarnotelEVedySDukoral, vaccin oral contre le choleraMed Trop (Mars)20066623723916924813
  • MorozovaOVSashinaTAFominaSGNovikovaNAComparative characteristics of the VP7 and VP4 antigenic epitopes of the rotaviruses circulating in Russia (Nizhny Novgorod) and the Rotarix and RotaTeq vaccinesArch Virol20151601693170325944143
  • GonzalezAMNguyenTVAzevedoMSAntibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOMClin Exp Immunol200413536137215008967
  • TateJECurnsATCorteseMMBurden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccinePediatrics200912374474919254997
  • HuangLMChangPFLeePIImmunogenicity and safety of Haemophilus influenzae type b conjugate vaccine (HibTITER) and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER (TETRAMUNE) in two-month-old infantsJ Microbiol Immunol Infect19983118018610496155
  • CryzSJJrPatient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21aJ Travel Med1998514179772310
  • ChenWHGreenbergRNPasettiMFSafety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banksClin Vaccine Immunol201421667324173028
  • HawkenJTroySBAdjuvants and inactivated polio vaccine: a systematic reviewVaccine2012306971697923041122
  • LandaverdeMVenczelLde QuadrosCAPoliomyelitis outbreak caused by vaccine-derived virus in Haiti and the Dominican RepublicRev Panam Salud Publica20019272274 Spanish11418973
  • PremanandBPrabakaranMKienerTKKwangJRecombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in micePLoS One20138e5553623390538
  • WackARappuoliRVaccinology at the beginning of the 21st centuryCurr Opin Immunol20051741141815950445
  • ReedSGBertholetSColerRNFriedeMNew horizons in adjuvants for vaccine developmentTrends Immunol200930233219059004
  • NazarianSGargariSLMRasooliIHasanniaSPiroozniaNA PLGA-encapsulated chimeric protein protects against adherence and toxicity of enterotoxigenic Escherichia coliMicrobiol Res201416920521223906742
  • VajdyMSrivastavaIPoloJDonnellyJO’HaganDSinghMMucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccinesImmunol Cell Biol20048261762715550120
  • ShakyaAKNandakumarKSApplications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseasesJ R Soc Interface2013102012053623173193
  • LisuloMMKapuluMCBandaRAdjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian menClin Exp Immunol201417546847524237035
  • UrataTArimoriKNakanoHModification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheresJ Control Release19995813314110053186
  • DelgadoALavelleECHartshorneMDavisSSPLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systemsVaccine1999172927293810438065
  • RoseFWernJEIngvarssonPTEngineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: a quality-by-design approachJ Control Release2015210485725957906
  • KreuterJBergULiehlESolivaMSpeiserPPInfluence of the particle size on the adjuvant effect of particulate polymeric adjuvantsVaccine198641251293727758
  • ChauvierreCManchandaRLabarreDVauthierCMardenMCLeclercLArtificial oxygen carrier based on polysaccharides-poly(alkylcyanoacrylates) nanoparticle templatesBiomaterials2010316069607420488532
  • CorradinGGiudiceGDNovel adjuvants for vaccinesCurr Med Chem2005417
  • EldridgeJHStaasJKMeulbroekJAMcGheeJRTiceTRGilleyRMBiodegradable microspheres as a vaccine delivery systemMol Immunol1991282872942017198
  • AndersonJSmithBPUlrichJTVaccination of calves with a modified bacterin or oil-in-water emulsion containing alkali-detoxified Salmonella-typhimurium lipopolysaccharideAm J Vet Res1991525966012053731
  • IgartuaMHernandezRMEsquisabelAGascónARCalvoMBPedrazJLEnhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheresJ Control Release19985663739801430
  • PrietoMJBDelieFFattalECharacterization of V3 BRU peptide-loaded small PLGA microspheres prepared by a (W(1)/O)W(2) emulsion solvent evaporation methodInt J Pharm1994111137145
  • ChaicumpaWParairoJRNewRCImmunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio-cholerae antigensAsian Pac J Allergy199088794
  • NayakBPandaAKRayPRayARFormulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccinationJ Microencapsul20092615416518608800
  • PrimardCRochereauNLucianiETraffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cellsBiomaterials2010316060606820471085
  • KimSYDohHJAhnJSInduction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticlesVaccine19991760761610075169
  • KimSYDohHJJangMHHaYJChungSIParkHJOral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticlesHelicobacter19994333910352085
  • KotloffKLSzteinMBWassermanSSLosonskyGADiLorenzoSCWalkerRISafety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infectionInfect Immun2001693581359011349017
  • JoshiVBGearySMSalemAKBiodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responsesHum Vaccines Immunother2013925842590
  • GutierroIHernandezRMIgartuaMGascónARPedrazJLSize dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheresVaccine200221677712443664
  • SamadiNAbbadessaADi StefanoAThe effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particlesJ Control Release201317243644323751568
  • CarcabosoAMHernandezRMIgartuaMRosasJEPatarroyoMEPedrazJLPotent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticlesVaccine2004221423143215063565
  • JiangTSinghBLiHSTargeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosanBiomaterials2014352365237324342722
  • MundargiRCBabuVRRangaswamyVNano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivativesJ Control Release200812519320918083265
  • JainAKGoyalAKMishraNVaidyaBMangalSVyasSPPEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis BInt J Pharm201038725326220005936
  • ArturssonPEdmanPLaaksoTSjöholmICharacterization of polyacryl starch microparticles as carriers for proteins and drugsJ Pharm Sci198473150715136440978
  • WikingssonLSjoholmIPolyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in miceVaccine2002203355336312213405
  • HeritagePLUnderdownBJBrookMAMcDermottMROral administration of polymer-grafted starch microparticles activates gut-associated lymphocytes and primes mice for a subsequent systemic antigen challengeVaccine199816201020079796058
  • AllcockHRKwonSAn ionically cross-linkable polyphosphazene-poly[bis(carboxylatophenoxy)phosphazene] and its hydrogels and membranesMacromolecules1989227579
  • PayneLGJenkinsSAWoodsALPoly[di(carboxylatophenoxy) phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccineVaccine19981692989607015
  • AndrianovAKMarinAChenJSynthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phosphazene]Biomacromolecules2006739439916398541
  • EngNFGarlapatiSGerdtsVBabiukLAMutwiriGKPCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigensJ Immune Based Ther Vaccines20108420735838
  • HariyadiDMMaYWangYThe potential for production of freeze-dried oral vaccines using alginate hydrogel microspheres as protein carriersJ Drug Deliv Sci Tec201424178184
  • BowersockTLShalabyWSWBlevinsWEPoly(methacrylic acid) hydrogels for rumen bypass and the delivery of oral vaccines to ruminantsAcs Sym Ser1994545214220
  • WuQJGongCYShiSMannan loaded biodegradable and injectable thermosensitive PCL-PEG-PCL hydrogel for vaccine deliverySoft Mater201210472486
  • JungTKammWBreitenbachAHungererKDHundtEKisselTTetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in micePharm Res20011835236011442276
  • BegSSamadANazishIColloidal drug delivery systems in vaccine deliveryCurr Drug Targets20131412313723072326
  • TomaliaDADendrimer researchScience199125212311232
  • BoasUHeegaardPMDendrimers in drug researchChem Soc Rev200433436314737508
  • NaharMDuttaTMurugesanSFunctional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactivesCrit Rev Ther Drug Carrier Syst20062325931817341200
  • ShahiwalaAVyasTKAmijiMMNanocarriers for systemic and mucosal vaccine deliveryRecent Pat Drug Deliv Formul200711919075870
  • ChakrabortyCPalSDossGPWenZHLinCSNanoparticles as “smart” pharmaceutical deliveryFront Biosci (Landmark Ed)2013181030105023747865
  • MisumiSMasuyamaMTakamuneNTargeted delivery of immunogen to primate M cells with tetragalloyl lysine dendrimerJ Immunol20091826061607019414757
  • PrabakaranMMadhanSPrabhuNGengGYNewRKwangJReverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in miceAntivir Res20108618018720153776
  • MarasiniNGiddamAKGhaffarKAMultilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A StreptococcusNanomedicine (Lond)2016111223123627077314
  • ChildersNKMichalekSMPritchardDGMcGheeJRMucosal and systemic responses to an oral liposome-Streptococcus mutans carbohydrate vaccine in humansReg Immunol199032892962132755
  • LiuJWuJWangBOral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infectionJ Med Virol20148688689424122866
  • HamblinKAWongJPBlanchardJDAtkinsHSThe potential of liposome-encapsulated ciprofloxacin as a tularemia therapyFront Cell Infect Microbiol201447924995163
  • DaiXYZhuangLHWangDDNuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cellsOncotarget201676933694726771844
  • ChildersNKDenysFRMcGeeNFMichalekSMUltrastructural study of liposome uptake by M cells of rat Peyer’s patch: an oral vaccine system for delivery of purified antigenReg Immunol199038162223559
  • LinTSChuangCCHsuHLRole of amphotericin B upon enhancement of protective immunity elicited by oral administration with liposome-encapsulated-Japanese encephalitis virus nonstructural protein 1 (NS1) in miceMicrob Pathog201049677420412849
  • OnuigboEBOkoreVCOfokansiKCPreliminary evaluation of the immunoenhancement potential of Newcastle disease vaccine formulated as a cationic liposomeAvian Pathol20124135536022834549
  • ChengHCChangCYHsiehFIEffects of tremella-alginate-liposome encapsulation on oral delivery of inactivated H5N3 vaccineJ Microencapsul201128556120945970
  • ClarkMABlairHLiangLBreyRNBraydenDHirstBHTargeting polymerised liposome vaccine carriers to intestinal M cellsVaccine20012020821711567766
  • ShuklaAMishraVKesharwaniPBilosomes in the context of oral immunization: development, challenges and opportunitiesDrug Discovery Today201621688889927038539
  • MannJFSShakirECarterKCMullenABAlexanderJFerroVALipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infectionVaccine2009273643364919464545
  • JainSIndulkarAHardeHAgrawalAKOral mucosal immunization using glucomannosylated bilosomesJ Biomed Nanotechnol20141093294724749389
  • ShuklaAKatareOPSinghBVyasSPM-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomesInt J Pharm2010385475219835938
  • ZhaoQFZhangQYueYInvestigation of 3D ordered macroporous carbon with different polymer coatings and their application as an oral vaccine carrierInt J Pharm201548723424125895720
  • SuksamranTNgawhirunpatTRojanarataTMethylated N-(4-N,N-dimethylaminocinnamyl) chitosan-coated electrospray OVA-loaded microparticles for oral vaccinationInt J Pharm2013448192723524125
  • ZhangLZengZZHuCHControlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccinesBiomaterials20167730731926624805
  • TurKMCh’ngHSEvaluation of possible mechanism(s) of bioadhesionInt J Pharm19981606174
  • JoyappaDHKumarCABanumathiNReddyGRSuryanarayanaVVCalcium phosphate nanoparticle prepared with foot and mouth disease virus P1-3CD gene construct protects mice and guinea pigs against the challenge virusVet Microbiol2009139586619505774
  • MercuriLPCarvalhoLVLimaFAOrdered mesoporous silica SBA-15: a new effective adjuvant to induce antibody responseSmall2006225425617193031
  • UlmerJBDeWittCMChastainMEnhancement of DNA vaccine potency using conventional aluminum adjuvantsVaccine199918182810501231
  • ZhangQZhaoQZhangYInvestigation of 3-D ordered materials with a high adsorption capacity for BSA and their potential application as an oral vaccine adjuvantJ Colloid Interface Sci201443411312125170604
  • PantarottoDPartidosCDGraffRSynthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptidesJ Am Chem Soc20031256160616412785847
  • Werengowska-CiecwierzKWisniewskiMTerzykAPConscious changes of carbon nanotubes cytotoxicity by manipulation with selected nanofactorsAppl Biochem Biotech2015176730741
  • WangTZouMJiangHJiZGaoPChengGSynthesis of a novel kind of carbon nanoparticle with large mesopores and macropores and its application as an oral vaccine adjuvantEur J Pharm Sci20114465365922064451
  • SnookJDChessonCBPenicheAGPeptide nanofiber-CaCO3 composite microparticles as adjuvant-free oral vaccine delivery vehiclesJ Mater Chem B2016416401649
  • CarvalhoLVRuizRDScaramuzziKImmunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15Vaccine2010287829783620937318
  • ZhaoDFengJHuoQTriblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom poresScience19982795485529438845
  • WangTJiangHZhaoQWangSZouMChengGEnhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological propertiesInt J Pharm201243635135822721849
  • NetoBPDda MataALMLLopesMVPreparation and evaluation of chitosan-hydrophobic silica composite microspheres: role of hydrophobic silica in modifying their propertiesPowder Technol2014255109119
  • MahdaviMMavandadnejadFYazdiMHOral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse modelJ Infect Public Health20171010210927026241
  • SalminenSBouleyCBoutron-RuaultMCFunctional food science and gastrointestinal physiology and functionBrit J Nutr199880S147S1719849357
  • LiuPSunYWangQSunYLiHDuanYIntracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomasBiomaterials20143576077024148242
  • OgueSTakahashiYOnishiHMachidaYPreparation of double liposomes and their efficiency as an oral vaccine carrierBiol Pharm Bull2006291223122816755021
  • ZhuQThomsonCWRosenthalKLMcDermottMRCollinsSMGauldieJImmunization with adenovirus at the large intestinal mucosa as an effective vaccination strategy against sexually transmitted viral infectionMucosal Immunol20081788819079163
  • ZhangLHuC-HChengS-XZhuoRXHyperbranched amphiphilic polymer with folate mediated targeting propertyColloids Surf B Biointerfaces20107942743320537873
  • ZhangLFanYWuYInositol based non-viral vectors for transgene expression in human cervical carcinoma and hepatoma cell linesBiomaterials2014352039205024314555
  • XingYYLiuWLiXKGuoLLvXXiTImmunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pyloriBiochem Biophys Res Commun201546226927425957472
  • KostenTDomingoCOrsonFKinseyBVaccines against stimulants: cocaine and MABrit J Clin Pharmaco201477368374
  • ZhangLHuCHChengSXZhuoRXPEI grafted hyperbranched polymers with polyglycerol as a core for gene deliveryColloid Surface B201076427433
  • SinghBMaharjanSJiangTCombinatorial approach of antigen delivery using M cell-homing peptide and mucoadhesive vehicle to enhance the efficacy of oral vaccineMol Pharmaceut20151238163828
  • YooMKKangSKChoiJHTargeted delivery of chitosan nanoparticles to Peyer’s patch using M cell-homing peptide selected by phage display techniqueBiomaterials2010317738774720656343
  • StertmanLLundgrenESjoholmIStarch microparticles as a vaccine adjuvant: only uptake in Peyer’s patches decides the profile of the immune responseVaccine2006243661366816513226
  • LebensMTerrinoniMKarlssonSLConstruction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio choleraeVaccine2016342121212826973069
  • HardeHSiddhapuraKAgrawalAKJainSDivalent toxoids loaded stable chitosan-glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administrationInt J Pharm201548729230425895719
  • GuptaPNKhatriKGoyalAKMishraNVyasSPM-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis BJ Drug Target20071570171318041638
  • NochiTYukiYMatsumuraAA novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responsesJ Exp Med20072042789279617984304
  • RashidIMoireNHerautBDimier-PoissonIMévélecMNEnhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal routeMed Microbiol Immunol2017206536227757545
  • YinYQinTWangXLinJYuQYangQCpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendritesMucosal Immunol2015879981425492476
  • LeitnerWWYingHRestifoNPDNA and RNA-based vaccines: principles, progress and prospectsVaccine19991876577710580187
  • LiYGTianFLGaoFSTangXSXiaCImmune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virusVaccine20072590291117028078
  • ChenSCJonesDHFynanEFProtective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticlesJ Virol199872575757619621034
  • FooksARSharpeSAShallcrossJACleggJCCranageMPInduction of immunity using oral DNA vaccines expressing the measles virus nucleocapsid proteinDev Biol20001046571
  • GamazoCIracheJMNanostructures for Oral Vaccine DeliveryAlonsoMJCsabaNSNanostructured Biomaterials for Overcoming Biological BarriersCambridgeRSC Publishing201291113
  • NegashTLimanMRautenschleinSMucosal application of cationic poly(D,L-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal diseaseVaccine2013313656366223777953
  • ChuDSSchellingerJGShiJConvertineAJStaytonPSPunSHApplication of living free radical polymerization for nucleic acid deliveryAcc Chem Res2012451089109922242774
  • UlmerJBMasonPWGeallARNA-based vaccinesVaccine2012304414441822546329
  • ZhuJWangYHuangHUpregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosisTumour Biol20163766167226242264